info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Drug Discovery Informatics Market Size

ID: MRFR//6360-HCR | 90 Pages | Author: Rahul Gotadki| February 2025

These industries are also witnessing marked increases in R & D activities, which have far-reaching effects on the drug discovery information market. Now that competition in drug discovery is hotter than ever, firms are increasingly seeking out analyses based on information technologies to help them through the process from target screening all the way up until lead optimization.
Science and technology developments greatly affect the drug discovery informatics market. Many innovations, such as artificial intelligence (AI), machine learning and data analytics are gradually being integrated into informatics platforms. These technologies boost data processing power, so researchers can draw useful inferences and speed up the development of new drugs.
Massive amounts of data are generated in the process of drug discovery-the management and analysis thereof are a major factor contributing to that market's functioning. Drug discovery informatics platforms that provide powerful offerings for dealing with large quantities of data, handling information integration and analysis help to make more intelligent decision making. The eventual result is a markedly shorter drug discovery pipeline.
In view of the stringent regulatory requirements imposed by health authorities, the drug discovery informatics market is under great pressure. Informatics solution providers must strictly comply with regulatory standards related to data integrity, security, and privacy. Those companies that can provide solutions which match or surpass these standards are able to gain an advantage in the marketplace.
A major market factor is the adaption of cloud computing for drug discovery informatics.
Because informatics solutions are cloud-based, they offer scalability and flexibility so that researchers can access and analyse data from any location. As the trend of cloud-building spreads, it is helping improve collaboration and data-sharing capabilities within the drug discovery system. Drug discovery informatics market is affected by the trend toward personalized medicine.
Informatics platforms capable of analysing patient data, genetic information and biomarkers are needed to identify possible targets for personalized therapies. As the trend toward precision medicine becomes more pronounced, people are increasingly looking for informatics solutions that suit different forms of individualized treatment.
A wider range of emerging markets is getting involved in drug discovery and a globalization of research efforts influence the market for informatics.

Covered Aspects:

Report Attribute/Metric Details
Market Size Value In 2022 USD 3.1 Billion
Market Size Value In 2023 USD 3.43 Billion
Growth Rate 10.8% (2023-2032)Base Year2022Market Forecast Period2023-2032Historical Data2018- 2022Market Forecast UnitsValue (USD Billion)Report CoverageRevenue Forecast, Market Competitive Landscape, Growth Factors, and TrendsSegments CoveredProduct, Mode, Service, and RegionGeographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the WorldCountries CoveredThe US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and BrazilKey Companies Profiled Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault SystèmesKey Market OpportunitiesProduct releases and R&D by significant critical playersKey Market DynamicsGrowing  emphasis on medication discoveryThere is a growing need to control medication discovery and development expenses.Increase in R&D spendingThe chronic illness burden is growing.
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.